Teva- Pharmaceutical Industries Ltd
NYSE: TEVA
$16.59
-$0.10 (-0.6%)
Closing Price on November 26, 2024
TEVA Articles
The top analyst upgrades, downgrades and other research calls from Tuesday include AK Steel, Carnival, FedEx, PayPal, Sunoco, Teva Pharmaceutical, Under Armour and Wells Fargo.
Published:
Alder Biopharmaceuticals saw its shares make a solid gain on Monday amid a blizzard of updates from the company.
Published:
Last Updated:
Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves in 2018.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva Pharmaceuticals, Tyson Foods, Walgreens Boots...
Published:
Last Updated:
The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
Published:
Last Updated:
Teva Pharmaceutical saw its shares make a small gain on Wednesday after the firm announced the exclusive launch of a generic version of Reyataz capsules in the United States.
Published:
Last Updated:
Teva Pharmaceutical Industries kicked off the week by announced an FDA for its treatment for migraines.
Published:
Last Updated:
Another company has decided that the best time to fire a large number of people is just before the holidays.
Published:
Last Updated:
The FCC has killed net neutrality, Disney has become the king of all media, holiday spending has been unusually strong, and more important headlines.
Published:
Last Updated:
Teva Pharmaceutical Industries shares turned south on Wednesday after the company said that it would be announcing its restructuring plan on Thursday.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
A generic version of Viagra is coming to America, but will existing customers be willing to switch over to a generic version of the pill?
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include Best Buy, Equifax, Gilead Sciences, MongoDB, NVIDIA, Rio Tinto, Teva Pharmaceutical and UPS.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Teva, General Electric, Newell Brands, and Oclaro all posted new 52-week lows Thursday.
Published:
Last Updated: